These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Prognostic significance of the combination of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients with renal cell carcinoma after nephrectomy. Peng D; Zhang CJ; Tang Q; Zhang L; Yang KW; Yu XT; Gong Y; Li XS; He ZS; Zhou LQ BMC Urol; 2018 Mar; 18(1):20. PubMed ID: 29544476 [TBL] [Abstract][Full Text] [Related]
10. Gender-based psychological and physical distress differences in patients diagnosed with non-metastatic renal cell carcinoma. Ajaj R; Cáceres JOH; Berlin A; Wallis CJD; Chandrasekar T; Klaassen Z; Ahmad AE; Leao R; Finelli A; Fleshner N; Goldberg H World J Urol; 2020 Oct; 38(10):2547-2554. PubMed ID: 31893313 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of hematologic parameters in patients with metastatic renal cell carcinoma using tyrosine kinase inhibitors. Gunduz S; Mutlu H; Uysal M; Coskun HS; Bozcuk H Asian Pac J Cancer Prev; 2014; 15(8):3801-4. PubMed ID: 24870797 [TBL] [Abstract][Full Text] [Related]
12. Regan isoenzyme of alkaline phosphatase as a tumour marker for renal cell carcinoma. Bukowczan J; Pattman S; Jenkinson F; Quinton R Ann Clin Biochem; 2014 Sep; 51(Pt 5):611-4. PubMed ID: 24615345 [TBL] [Abstract][Full Text] [Related]
13. Examination of moderators of expressive writing in patients with renal cell carcinoma: the role of depression and social support. Milbury K; Lopez G; Spelman A; Wood C; Matin SF; Tannir NM; Jonasch E; Pisters L; Wei Q; Cohen L Psychooncology; 2017 Sep; 26(9):1361-1368. PubMed ID: 27145447 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer. Ramsey S; Lamb GW; Aitchison M; Graham J; McMillan DC Cancer; 2007 Jan; 109(2):205-12. PubMed ID: 17149754 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of risk stratification using blood parameters for nivolumab in Japanese patients with metastatic renal-cell carcinoma. Yamamoto Y; Matsuyama H; Matsumoto H; Sakano S; Fuji N; Oba K; Yamamoto M; Kamiryo Y; Hiragino T; Nagao K; Takai K; Aoki A Jpn J Clin Oncol; 2020 Feb; 50(2):214-220. PubMed ID: 31755525 [TBL] [Abstract][Full Text] [Related]
16. Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: a retrospective study. Johnson AC; Matias M; Boyle H; Escudier B; Molinier A; Laguerre B; Helissey C; Brachet PE; Dugué AE; Mourey L; Coquan E; Joly F BMC Cancer; 2017 May; 17(1):355. PubMed ID: 28532444 [TBL] [Abstract][Full Text] [Related]
18. Albumin levels predict prognosis in advanced renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis. Zhou X; Fu G; Zu X; Xu Z; Li HT; D'souza A; Tulpule V; Quinn DI; Bhowmick NA; Weisenberger DJ; Liang G; Chen J Urol Oncol; 2022 Jan; 40(1):12.e13-12.e22. PubMed ID: 34454823 [TBL] [Abstract][Full Text] [Related]
19. Distress in patients with renal cell carcinoma: a curious gap in knowledge. Bergerot CD; Battle D; Staehler MD; Pal SK BJU Int; 2019 Feb; 123(2):208-209. PubMed ID: 30253048 [No Abstract] [Full Text] [Related]
20. Preoperative albumin to globulin ratio predicts survival in clear cell renal cell carcinoma patients. Chen Z; Shao Y; Yao H; Zhuang Q; Wang K; Xing Z; Xu X; He X; Xu R Oncotarget; 2017 Jul; 8(29):48291-48302. PubMed ID: 28187463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]